Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Nadia Sam-Agudu"'
Autor:
Jibreel Jumare, Patrick Dakum, Nadia Sam-Agudu, Peter Memiah, Rebecca Nowak, Florence Bada, Uzoamaka Oguama, George Odonye, Ruxton Adebiyi, Cristiana Cairo, Vivian Kwaghe, Clement Adebamowo, Alash’le Abimiku, Man Charurat
Publikováno v:
BMC Endocrine Disorders, Vol 23, Iss 1, Pp 1-15 (2023)
Abstract Background Persons living with HIV (PLHIV) now live longer due to effective combination antiretroviral therapy. However, emerging evidence indicates that they may be at increased risk for some cardiometabolic disorders. We compared the preva
Externí odkaz:
https://doaj.org/article/7d41c05d52ec41bfa2c6c3a4261f4a9d
Autor:
Olusegun A Adeyemi, Rebecca G Nowak, Mark Marzinke, Daniel Morgan, Nadia Sam-Agudu, Jaih Craddock, Min Zhan, Trevor A Crowell, Stefan Baral, Nicaise Ndembi, Sylvia Adebajo, Manhattan E Charurat, TRUST/RV368 Study Group
Publikováno v:
PLoS ONE, Vol 18, Iss 3, p e0282999 (2023)
IntroductionHIV pre-exposure prophylaxis (PrEP) significantly reduces the risk of HIV acquisition. However, studies have demonstrated discordance between self-reported measures and biomedical benchmarks of PrEP adherence. We estimated the correlation
Externí odkaz:
https://doaj.org/article/d6303d5405214cedbe6012c83c800d83
Autor:
Fadimatu Yunusa, MPH, Maryam Bello, BSc, Gbenga A Kayode, PhD, Adeoye Adegboye, MPH, Geraldine Abone, MBBS, Fati Murtala-Ibrahim, B Pharm, Martha Okposo, MSc, Atinuke Anjorin, MBBS, Saswata Dutt, MBBS, Oche Yusuf, MHM, Nadia Sam-Agudu, Patrick Dakum, MPH
Publikováno v:
The Lancet Global Health, Vol 8, Iss , Pp S37- (2020)
Background: Tuberculosis is a main cause of death in people living with HIV and results in around 39 000 deaths every year in Nigeria. Isoniazid preventive therapy (IPT), the standard tuberculosis preventive therapy used in Nigeria, has been shown to
Externí odkaz:
https://doaj.org/article/13839da24bfb407db5dab23fd676c197
Autor:
Echezona E. Ezeanolue, Theddeus Iheanacho, Dina V. Patel, Shatabdi Patel, Nadia Sam-Agudu, Michael Obiefune, Patrick Dakum, Prosper Okonkwo, Ayodotun Olutola, Hadiza Khamofu, Bolanle Oyeledun, Sani Aliyu, Muyiwa Aina, Andy Eyo, John Oko, Timothy Akinmurele, Obinna Oleribe, Usman Gebi, Muktar H. Aliyu, Rachel Sturke, George Siberry
Publikováno v:
Annals of Global Health, Vol 85, Iss 1 (2019)
Background: Contextual research evidence is needed to reduce morbidity and mortality due to chronic but preventable diseases in low- and middle-income countries. Nigeria, Africa’s most populous country, is particularly burdened by these diseases de
Externí odkaz:
https://doaj.org/article/d19f32d43e51437ab0d53c6a2be4ea54
Autor:
Oriaku Ofem, MD, Tongdiyen Laura Jasper, MD, Nguavese Torbunde, MD, Murna Yashimankut, MD, Hussaini Sadiq, BSc, Rosemary Ejekam, MD, Daniel Ikeda, BA, Emmanuel Aiyenigba, MD, Bruce Agins, MD, Nadia Sam-Agudu, MD
Publikováno v:
The Lancet Global Health, Vol 7, Iss , Pp S23- (2019)
Background: Nigeria has the second highest burden of HIV in children younger than 15 years (220 000) and adolescents 10 –19 years (230 000) in the world. Unfortunately, fewer than a quarter of these children and adolescents are identified and given
Externí odkaz:
https://doaj.org/article/ad71ecbbb4874938bb4121b99bf9a41e
Autor:
Tom G Jacobs, Stef Schouwenburg, Martina Penazzato, Moherndran Archary, Theodore D Ruel, John van den Anker, David M Burger, Tim R Cressey, Elaine J Abrams, Hermione Lyall, Adrie Bekker, Angela Colbers, David Burger, Tim Cressey, Deborah Hirt, Irja Lutsar, Helen Mcilleron, Joe Standing, John Van den Anker, Elin Svensson, Elaine Abrams, Pauline Amuge, Mo Archary, Yodit Belew, Brookie Best, Helen Bygrave, Edmund Capparelli, Esther Casas, Diana Clarke, Polly Clayden, Mutsa Dangarembizi, Roberto De Lisa, Paolo Denti, Paul Domanico, Shaffiq Essajee, Lisa Frigati, Carlo Giaquinto, Diana Gibb, Stephanie Hackett, Rohan Hazra, Marc Lallemant, Linda Lewis, Shahin Lockman, Imelda Mahaka, Betsy McFarland, Cathal Meere, Fatima Mir, Mark Mirochnick, Lynne Mofenson, Irene Mukui, Angela Mushavi, Victor Musiime, Eleanor Namusoke-Magongo, Elisabeth Obimbo, Mary Atieno Ojoo, Roger Parades, Carmen Perez-Casas, Manuele Piccolis, Jorge Pinto, Thanyawee Puthanakit, Natella Rakhmanina, Annette Reinisch, Pablo Rojo, Vanessa Rouzier, Ted Ruel, Nadia Sam-Agudu, George Siberry, Teresa Simione, Katie Simon, Vindi Singh, Manjari Solares, Nandita Sugandhi, Mariam Sylla, Ibou Thior, Anna Turkova, Marissa Vicari, Jenny Walsh, Melynda Watkins, Hilary Wolf, Asma Hafiz, Ajay Rangaraj, Meg Doherty, Marco Vitoria
Publikováno v:
The Lancet HIV, 9, 9, pp. e649-e657
The Lancet HIV, 9, e649-e657
The Lancet HIV, 9, e649-e657
Item does not contain fulltext Although 23 antiretroviral drugs are approved for use in adults, only six are approved by regulatory authorities for use in term neonates born to women with HIV, with even fewer options for preterm neonates. A major hur
Autor:
Olusegun Adeyemi, Rebecca Nowak, Daniel Morgan, Nadia Sam-Agudu, Jaih Craddock, Min Zhan, Trevor Crowell, Stefan Baral, Sylvia Adebajo, Manhattan Charurat
Background: Pre-exposure prophylaxis (PrEP) effectively prevents HIV acquisition but may be associated with an elevated risk of other sexually transmitted infections (STIs) due to increased condomless anal intercourse (CAI) among sexual and gender mi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1babf18585ab2965ffbe2c8b1218789
https://doi.org/10.21203/rs.3.rs-1979738/v1
https://doi.org/10.21203/rs.3.rs-1979738/v1
Autor:
Martina Penazzato, Claire L Townsend, Nadia A Sam-Agudu, Theodore D Ruel, Moherndran Archary, Adrie Bekker, Tim R Cressey, Angela Colbers, Nandita Sugandhi, Pablo Rojo, Natella Rakhmanina, Melynda Watkins, Lisa Frigati, Irene Mukui, Asma Hafiz, Marissa Vicari, Edmund V Capparelli, Elaine J Abrams, Elaine Abrams, Edmund Capparelli, Tim Cressey, Theodore Ruel, Nadia Sam-Agudu, Claire Townsend
Publikováno v:
The Lancet HIV, 9, 9, pp. e658-e666
The Lancet HIV, 9, e658-e666
The Lancet HIV, 9, e658-e666
Item does not contain fulltext Safe and effective paediatric formulations of the most promising antiretroviral drugs are crucial to advance the treatment and prevention of HIV in neonates, infants, children, and adolescents. The WHO Paediatric Drug O